Achyut Healthcare Share Price Today | Stock Price & Achyut Healthcare Share Screener
As of October 5, 2026, the live Achyut Healthcare share price (BSE: ACHYUT) is ₹5.74, down 2.88% from the previous close, with shares trading between ₹5.62 and ₹6.10 in today's trading session, and a 52-week range of ₹4.90–₹9.13. Check ACHYUT price range for the annual price range and momentum. Use the Achyut Healthcare stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Achyut Healthcare opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Achyut Healthcare Share Price Chart
Track the current stock price of Achyut Healthcare with an interactive chart. Analyse ACHYUT share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Achyut Healthcare stock quote in one place.
The quote of ₹5.74 sits between the 52-week low of ₹4.90 and the 52-week high of ₹9.13, and the latest session moved -2.88% from the previous close.
Achyut Healthcare Company Profile - Fundamental Screener
Screen Achyut Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ACHYUT shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0K1401020.
Company Details
Classification
Identifiers and Leadership
Achyut Healthcare Balance Sheet Screener
Screen ACHYUT balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹38, up from ₹34 in 2025.
Latest statistics put total assets at ₹38 and shareholder funds at ₹35, with a leverage ratio of 0.05.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 38 | 34 | 31 | 15 | 10 | 1 | 0 | 0 |
| Current Assets | 8 | 10 | 22 | 10 | 8 | 0 | 0 | 0 |
| Fixed Assets | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 35 | 31 | 31 | 15 | 9 | 0 | 0 | 0 |
| Share Capital | 24 | 24 | 17 | 9 | 7 | 0 | 0 | 0 |
| Reserves & Surplus | 11 | 8 | 14 | 5 | 2 | 0 | 0 | 0 |
Achyut Healthcare Income Statement Screener - Profit & Revenue Analysis
Screen Achyut Healthcare income statement and profit fundamentals. Analyze ACHYUT quarterly results. Achyut Healthcare reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹12 and net profit was ₹0, at an operating margin of 2%.
In that period expenses were ₹12, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹12 and net profit of ₹0.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||
| Revenue | 12 | 12 | 4 | 7 | 3 | 4 | 0 | 0 | 1 |
| Expenses | 12 | 11 | 3 | 6 | 3 | 4 | 0 | 0 | 1 |
Operating Costs and Margins | |||||||||
| EBITDA | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 2.00% | 2.00% | -5.00% | 0.00% | -10.00% | -1.00% | 4.00% | 2.00% | 2.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||
| Profit Before Tax | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| EPS | 0.00 | 0.01 | 0.02 | 0.34 | 0.25 | 0.15 | 0.22 | 0.56 | -0.58 |
Achyut Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen ACHYUT cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities generated ₹1, and net cash flow was an inflow of ₹2.
Over the same period, investing activities used ₹2 and financing activities provided ₹3.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | 1 | -4 | 0 | 0 | -7 | 0 | 0 | 0 |
| Investing Activities | -2 | -2 | -15 | -5 | -2 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||
| Financing Activities | 3 | 0 | 16 | 5 | 9 | 0 | 0 | 0 |
| Net Cash Flow | 2 | -6 | 0 | 0 | 0 | 0 | 0 | 0 |
Achyut Healthcare Shareholding Pattern Screener
See Achyut Healthcare shareholding pattern with promoter, FII, and DII holdings. Check Achyut Healthcare promoter holding and ownership changes for ACHYUT on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 47.40%, foreign institutions 5.13%, domestic institutions 0.00% and the public 42.83%, spread across 518 shareholders.
The shareholder count was 518 in 2026-Mar, compared with 3,174 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 47.40% | 47.40% | 46.11% | 46.38% | 47.07% | 47.71% | 44.80% | 46.11% |
Institutional Investors | ||||||||
| FII Holding | 5.13% | 5.13% | 8.14% | 6.14% | 5.26% | 5.26% | 0.00% | 6.14% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 42.83% | 42.70% | 39.82% | 43.37% | 43.66% | 43.07% | 37.34% | 36.77% |
| Other Holding | 4.64% | 4.77% | 5.92% | 4.12% | 4.01% | 3.96% | 17.87% | 10.98% |
| Shareholder Count | 518 | 3,174 | 524 | 541 | 565 | 519 | 179 | 193 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Achyut Healthcare. Achyut Healthcare dividend yield can be compared with peers and other stocks in the market.
Achyut Healthcare Stock Index Membership - Nifty & Sensex
See which indices include Achyut Healthcare stock. Check ACHYUT index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Achyut Healthcare Market Events Screener - Corporate Actions
Get Achyut Healthcare corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Achyut Healthcare stock events that may affect ACHYUT share price, along with derivatives, futures and options activity and sector gainers.
15 corporate actions are listed, the most recent entry being Annual General Meeting dated September 29, 2026, with a record date of September 29, 2026.
It is followed by Quarterly Result Announcement dated August 13, 2026 and Quarterly Result Announcement dated May 27, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-29 | 2026-09-29 | Annual General Meeting | NA | -7.45% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | 3.37% |
| 2026-05-27 | 2026-05-27 | Quarterly Result Announcement | NA | 17.24% |
| 2026-02-19 | 2026-02-19 | Extraordinary General Meeting | NA | 4.51% |
| 2026-01-21 | 2026-01-21 | Quarterly Result Announcement | NA | -4.15% |
| 2025-10-16 | 2025-10-16 | Quarterly Result Announcement | NA | 0.00% |
| 2025-09-30 | 2025-09-30 | Annual General Meeting | NA | 20.04% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | 0.30% |
| 2024-12-10 | 2024-12-10 | Split | 1:10 | 20.72% |
| 2024-12-10 | 2024-12-10 | Bonus | 4:10 | 19.21% |
| 2024-11-19 | 2024-11-19 | Extraordinary General Meeting | NA | -4.86% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 29.95% |
| 2024-09-30 | 2024-09-30 | Annual General Meeting | NA | 1.96% |
| 2023-12-15 | 2023-12-15 | Extraordinary General Meeting | NA | -92.92% |
| 2023-04-25 | Bonus | 1:2 | - |
Achyut Healthcare Competitors Screener - Peer Stocks Comparison
Screen ACHYUT competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Achyut Healthcare Company Announcements - News & Reports Screener
Screen ACHYUT latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated and October 1, 2026.
| Date | Update | Actions |
|---|---|---|
| Outcome Of AGM | - | |
| Shareholder Meeting / Postal Ballot-Outcome of AGM | - | |
| 2026-10-01 | Closure of Trading Window | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Reg. 34 (1) Annual Report. | - |
| 2026-09-05 | Cut-Off Date For Notice Of 31St Annual General Meeting (AGM) F.Y.2025-2026 | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-09-05 | Outcome Of The Meeting Of Board Of Directors Held On 05Th September 2026 | - |
| 2026-09-05 | Notice Of 31St Annual General Meeting Of The Company For F.Y. 2025-26 To Be Held On 29Th September 2026. | - |
| 2026-09-05 | Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 05Th September 2026 | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Statement Of Deviation/Variation For Quarter Ended June 30 2026 | - |
| 2026-08-13 | Financial Results For Quarter Ended June 30 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Outcome Of Board Meeting | - |
| 2026-08-07 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday August 13 2026 | - |
| 2026-07-15 | Board Meeting Outcome for Revised Outcome | - |
| 2026-07-14 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | - |
| 2026-07-14 | Corporate Action-Amalgamation/ Merger / Demerger | - |
| 2026-07-14 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Tuesday July 14 2026 And The Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations 2015 Approval Of The Scheme Of Amalgamation Of Achyut Healthcare Limited With And Into Zenith H | - |
| 2026-07-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹5.74, within a 52-week range of ₹4.90 to ₹9.13. The P/B ratio is 4.45. Market capitalisation stands at ₹150.11 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 5, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.